GlassScriptPhysician profile
Louis T Curtis
NPI 1568085959
$4,962.96
in general payments reported to CMS, 2019-2025
38 companies · $3,436 in 2025
The $3,436 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,526 · 2025: $3,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,782 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,782.25 |
| Education | $180.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $810.34 | 2024-2025 | |
| Ucb, INC. | $495.02 | 2024-2025 | Rystiggo, Briviact, Fintepla |
| Eisai INC. | $377.33 | 2024-2025 | |
| Janssen Biotech, INC. | $294.64 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $244.93 | 2024-2025 | Hyqvia |
| Catalyst Pharmaceuticals, INC. | $240.25 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $216.90 | 2024 | Ultomiris |
| Tg Therapeutics, INC. | $195.36 | 2024-2025 | |
| Csl Behring | $181.21 | 2024-2025 | Hizentra, Kcentra |
| Argenx US, INC. | $172.61 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Amgen INC. | $145.29 | 2024-2025 | Uplizna |
| Neurelis, INC. | $143.70 | 2024-2025 | Valtoco |
| Pfizer INC. | $131.01 | 2024 | |
| Novartis Pharmaceuticals Corporation | $110.58 | 2024-2025 | |
| Genentech USA, INC. | $109.68 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $109.43 | 2025 | Ponvory |
| Alnylam Pharmaceuticals INC. | $100.85 | 2024-2025 | Onpattro |
| Lilly USA, LLC | $93.62 | 2024-2025 | Amyvid, Kisunla |
| Monteris Medical Corporation | $91.20 | 2025 | Neuroblate |
| Genzyme Corporation | $86.85 | 2024-2025 | |
| Emd Serono, INC. | $69.13 | 2024-2025 | |
| Amneal Pharmaceuticals LLC | $51.41 | 2024-2025 | Crexont, Ongentys 50mg Capsules 30 |
| Azurity Pharmaceuticals, INC. | $50.35 | 2024-2025 | Horizant |
| Springworks Therapeutics, INC. | $49.70 | 2025 | Gomekli |
| Ani Pharmaceuticals, INC. | $48.81 | 2025 | Purified Cortrophin Gel |
| Biogen, INC. | $45.89 | 2024-2025 | Vumerity, Tysabri |
| Lundbeck LLC | $37.74 | 2025 | Vyepti |
| Merz Pharmaceuticals, LLC | $35.97 | 2025 | Inbrija, Xeomin |
| Aucta Pharmaceuticals, INC. | $29.37 | 2025 | Motpoly Xr |
| Teva Pharmaceuticals USA, INC. | $25.14 | 2025 | Austedo Xr |
| Banner Life Sciences, LLC | $24.30 | 2024 | |
| Chiesi USA, INC. | $23.95 | 2024 | Cleviprex |
| Jazz Pharmaceuticals INC. | $22.41 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $21.88 | 2025 | |
| Smith+Nephew, INC. | $21.87 | 2025 | Pico 14, Pico 7 |
| Grifols USA, LLC | $18.61 | 2025 | Gamunex-C |
| Acadia Pharmaceuticals INC | $18.45 | 2025 | Nuplazid |
| Ipsen Biopharmaceuticals, INC | $17.18 | 2025 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.